Please login to the form below

Not currently logged in
Email:
Password:

NGF

This page shows the latest NGF news and features for those working in and with pharma, biotech and healthcare.

FDA fast-tracks Pfizer and Lilly's tanezumab

FDA fast-tracks Pfizer and Lilly's tanezumab

Pfizer and Lilly have been in a three-horse race to bring the first NGF inhibitor to market. ... Prior to the many clinical setbacks, analysts had predicted NGF inhibitors could become an $11bn drug category.

Latest news

  • FDA halts study of Teva and Regeneron's pain drug fasinumab FDA halts study of Teva and Regeneron's pain drug fasinumab

    The FDA placed a clinical hold on a phase IIb trial of Teva and Regeneron's nerve growth factor (NGF) inhibitor fasinumab in chronic lower back pain on safety concerns. ... Arthropathy has been seen before with NGF inhibitors - and caused the agency to

  • Takeda hands back rights to two Amgen drugs Takeda hands back rights to two Amgen drugs

    Last month however Sanofi said its fasinumab candidate had performed well in a phase II/III trial, raising hopes that NGF inhibition remains a valid drug target. ... Analysts have suggested that a successful NGF inhibitor could be a blockbuster as it

  • Lilly planning 20 new launches by 2023 Lilly planning 20 new launches by 2023

    Pfizer-partnered NGF inhibitor tanezumab for osteoarthritis pain, chronic lower back pain and cancer pain.

  • Regeneron says anti-NGF fasinumab works in pain Regeneron says anti-NGF fasinumab works in pain

    Regeneron says anti-NGF fasinumab works in pain. Clinical trial shows promise for opioid alternative. ... NGF has been targeted for years because it operates at the heart of multiple pain-signalling pathways.

  • J&J drops NGF blocker fulranumab J&J drops NGF blocker fulranumab

    J&J drops NGF blocker fulranumab. Says decision to return rights to Amgen based on “ strategic portfolio prioritisation”. ... Johnson &Johnson has returned the rights to fulranumab to Amgen, raising another question mark over the role of nerve growth

More from news
Approximately 4 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics